Portrait of Delaney, April McClain

Delaney, April McClain

U.S. Representative MD-6 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
486
Buys / sells
47% / 53%
Last trade
Aug 25, 2026
Last filing
Sep 9, 2026

Latest disclosed trades

Latest 10 of 486
Ticker Type Traded
HUBB Sell Aug 25, 2026
ROL Sell Aug 25, 2026
TDY Sell Aug 25, 2026
LTH Sell Aug 25, 2026
WAB Sell Aug 25, 2026
MLM Sell Aug 25, 2026
TDG Sell Aug 25, 2026
LYV Sell Aug 25, 2026
SGI Sell Aug 25, 2026
FWONK Sell Aug 25, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Delaney, April McClain stock trade activity

FilingIQ has indexed 486 congressional stock trade disclosures for Delaney, April McClain. The most recent disclosed transaction is dated Aug 25, 2026.

Across the full history, 229 purchases and 256 sales have been disclosed under the STOCK Act.

Top tickers traded by Delaney, April McClain

Frequently asked

How many stock trades has Delaney, April McClain disclosed?
FilingIQ tracks 486 Periodic Transaction Report disclosures for Delaney, April McClain, with the most recent dated Aug 25, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Delaney, April McClain a net buyer or net seller?
Across the disclosed trade history, 229 (47%) were purchases and 256 (53%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Delaney, April McClain come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.